Soligenix applies for CEPI funding to develop Bundibugyo Ebola vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to Soligenix applies for CEPI funding to develop Bundibugyo Ebola vaccine
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $4.35 
Open $0.38    52 Week Low $0.44 
Day High $0.38    P/E N/A 
Day Low $0.37    EPS $-0.81 
Volume 9,730